Form 4: Procter & Gamble Executive Balaji Purushothaman Reports Stock Option Grant
SEC Form 4 Filing
Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble, reports the acquisition of stock options and ownership of common stock.
Summary
- On September 13, 2024, Balaji Purushothaman, Chief Human Resources Officer of Procter & Gamble, reported transactions related to the company's stock.
- Purushothaman acquired 10,593 stock options with an exercise price of $174.08, exercisable from September 13, 2027, and expiring on September 13, 2034.
- Following the reported transactions, Purushothaman directly owns 11,565.9989 shares of common stock and indirectly owns 4,494.3805 shares through a retirement plan trustee.
- The transactions were reported on Form 4, filed with the Securities and Exchange Commission.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard executive compensation practice. It's neither particularly positive nor negative from an investment perspective.
Positives
- The acquisition of stock options aligns the executive's interests with those of the shareholders, incentivizing performance and value creation.
Industry Context
Executive compensation, including stock options, is a common practice in publicly traded companies to incentivize performance and align management's interests with those of shareholders. The details of these arrangements are closely watched by investors.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in companies of Procter & Gamble's size and industry.
- The specific terms of the grant, such as the exercise price, vesting schedule, and expiration date, are generally benchmarked against peer companies to ensure competitiveness and alignment with performance goals.
- Companies like Unilever, Nestle, and Johnson & Johnson also utilize stock options as part of their executive compensation plans.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of the shareholders, potentially leading to increased shareholder value.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock option grant and earliest transaction. |
| 09/13/2027 | Date the stock options become exercisable. |
| 09/13/2034 | Expiration date of the stock options. |
| 09/16/2024 | Date the Form 4 was signed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.